Clinical considerations for the anesthesiologist whose patient is on anticoagulant therapy.
D000758:Anesthesia; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use*; D001463:Barbiturates; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000188:drug therapy; D001779:Blood Coagulation Factors; D001803:Blood Transfusion; D002697:Chloral Hydrate; D003374:Coumarins / Q000627:therapeutic use; D004347:Drug Interactions; D005167:Factor VII; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006494:Heparin Antagonists / Q000627:therapeutic use; D006801:Humans; D008991:Monitoring, Physiologic; D011479:Protamines / Q000627:therapeutic use; D011517:Prothrombin Time; D012756:Sheep; D013514:Surgical Procedures, Operative; D013997:Time Factors; D014812:Vitamin K / Q000008:administration & dosage
D000925:Anticoagulants; D001463:Barbiturates; D001779:Blood Coagulation Factors; D003374:Coumarins; D006494:Heparin Antagonists; D011479:Protamines; D014812:Vitamin K; D002697:Chloral Hydrate; D005167:Factor VII; D006493:Heparin